European variations for medicinal products for human use

White papers - 22 March 2021

European variations for medicinal products for human use

Variations are any change to the currently approved content of a Marketing Authorisation (MA) dossier and are essential in the lifecycle management of a medicinal product. For human use, this mainly concerns articles 8(3), 9, 10, 10a, 10b, 10c of Directive 2001/83/EC and Annex I thereto, as well as article 6(2) Regulation 726/2004/EC.

 

In accordance with Commission Regulation (EU) No 1234/2008 (the ‘Variations Regulation’), and as amended by Regulation (EC) No. 712/2012, variations to Marketing Authorisations include Type IA, Type IAIN, Type IB, Type II and extension applications.

 


The following applies to medicinal products for human use approved through Mutual Recognition Procedure (MRP), Decentralised Procedures (DCP) and Centralised Approved Products (CAPs), and authorisations granted following a Committee for Medicinal Products for Human Use (CHMP) full harmonisation referral.

 

Homeopathic and traditional medicinal products (which have no marketing authorisation but are subject to simplified registration procedures) are not concerned by this Regulation.

 

    Dowload The Case Study


    By sending this form, I agree that my personal data will be saved and processed according to data protection regulations and will be used only for commercial and marketing purposes only.

    Learn more


    BlueReg undertakes to comply with the regulations in force applicable to the processing of personal data and, in particular, Regulation (EU) 2016/679 of the European Parliament and of the Council of 27 April 2016 applicable as from 25 May 2018 (hereinafter, "the General Data Protection Regulations" or GPDR) and the national laws resulting therefrom.
    Any inquiries, correction or declaration of event related to personal data processed should be sent to:

    GDPR data request


    Thank you for your reply

    The file will be sent to you by email.

    Download